Economics ❯ Market Trends

Pharmaceutical Market

Drug Pricing Drug Sales Investment Opportunities Investment Strategies Drug Demand Stock Performance Sales Performance COVID-19 Impact Investment Biopharmaceutical Growth Out-licensing Online Sales Growth Growth Projections Pricing Strategies Argentina Price Increases Investment Deals Obesity Market Investment in Biotech Sales Projections Supply Chain AI Market Growth Competition Generic Drug Sales Generics Revenue Decline Investment Shifts

Pfizer Tops Q4 Estimates but Posts Loss on $4.4 Billion Charge, Reaffirms 2026 Outlook

Management reiterates a flat 2026 outlook centered on cost cuts, obesity programs, pivotal trials.

AstraZeneca Strikes $1.2 Billion CSPC Pact for Once‑Monthly Obesity and Diabetes Programs

GSK Closes $12 Billion Licensing Pact for Hengrui’s COPD Therapy and 11 Preclinical Assets

BioNTech to Acquire CureVac for $1.25 Billion to Drive mRNA Cancer Therapy